Project Details
Project Description
| Status | Finished |
|---|---|
| Effective start/end date | 2/04/24 → 2/04/26 |
Keywords
- clinical trial
- Esophagitis
- Barzolvolimab
Clinical Trial Phase
- Phase II
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The “EvolvE” Study)
- Burgell, Rebecca (Primary Chief Investigator (PCI))
Project: Research